Arcellx, Inc. (ACLX)
NASDAQ: ACLX · Real-Time Price · USD
88.29
+3.08 (3.61%)
At close: Oct 8, 2025, 4:00 PM EDT
87.50
-0.79 (-0.89%)
After-hours: Oct 8, 2025, 4:28 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Cell Therapies
107.94M
Log In
Cell Therapies Growth
-2.16%
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
United States
107.94M
Log In
United States Growth
-2.16%
Log In